CN102274468B - Chinese medicinal composition for regulating female internal secretion and preparation method thereof - Google Patents
Chinese medicinal composition for regulating female internal secretion and preparation method thereof Download PDFInfo
- Publication number
- CN102274468B CN102274468B CN 201110249809 CN201110249809A CN102274468B CN 102274468 B CN102274468 B CN 102274468B CN 201110249809 CN201110249809 CN 201110249809 CN 201110249809 A CN201110249809 A CN 201110249809A CN 102274468 B CN102274468 B CN 102274468B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- treatment
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 10
- 230000028327 secretion Effects 0.000 title abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims description 28
- 241000756943 Codonopsis Species 0.000 claims description 10
- 241000407170 Curcuma Species 0.000 claims description 7
- 235000014375 Curcuma Nutrition 0.000 claims description 7
- 241000202807 Glycyrrhiza Species 0.000 claims description 7
- 241000208966 Polygala Species 0.000 claims description 7
- 241000545442 Radix Species 0.000 claims description 7
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 2
- 230000032683 aging Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 210000001672 ovary Anatomy 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 2
- 230000009545 invasion Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 235000010755 mineral Nutrition 0.000 abstract description 2
- 239000011707 mineral Substances 0.000 abstract description 2
- 235000013619 trace mineral Nutrition 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 2
- 241000212322 Levisticum officinale Species 0.000 abstract 2
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract 2
- 108010012715 Superoxide dismutase Proteins 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 239000001645 levisticum officinale Substances 0.000 abstract 2
- 210000004233 talus Anatomy 0.000 abstract 2
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 1
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 230000003833 cell viability Effects 0.000 abstract 1
- 230000001143 conditioned effect Effects 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001215 curcuma longa l. root Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002633 protecting effect Effects 0.000 abstract 1
- 239000002699 waste material Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 230000016087 ovulation Effects 0.000 description 12
- 239000000284 extract Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 6
- 102000009151 Luteinizing Hormone Human genes 0.000 description 6
- 108010073521 Luteinizing Hormone Proteins 0.000 description 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 239000012535 impurity Substances 0.000 description 4
- 230000002611 ovarian Effects 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000003946 Prolactin Human genes 0.000 description 3
- 108010057464 Prolactin Proteins 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 229960005309 estradiol Drugs 0.000 description 3
- 229930182833 estradiol Natural products 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000186 progesterone Substances 0.000 description 3
- 229960003387 progesterone Drugs 0.000 description 3
- 229940097325 prolactin Drugs 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 235000002673 Dioscorea communis Nutrition 0.000 description 2
- 241000544230 Dioscorea communis Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000035753 Periorbital contusion Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for regulating female internal secretion. The Chinese medicinal composition comprises the following raw materials in parts by mass: 20-40 parts of astragalus, 10-20 parts of Chinese angelica, 10-20 parts of dangshen, 10-20 parts of szechuan lovage rhizome, 10-20 parts of epimedium herb, 10-20 parts of dahurian patrinia herb, 3-10 parts of liquoric root, 5-10 parts of turmeric root tuber, 5-15 parts of thinleaf milkwort rootbark and 3-10 parts of evodia fruit. HGH (Human Growth Hormone) active factors and antioxidase extracted from traditional Chinese medicinal materials such as astragalus, Chinese angelica, dangshen, szechuan lovage rhizome and the like with a modern process can be used for enhancing the cell viability of a human body, replenishing qi, nourishing blood, accelerating excretion of in-vivo metabolic waste, facilitating blood circulation and secretion of female ovary hormone and replenishing various amino acids, organized enzymes, minerals and trace elements needed by a human body, so that the internal secretion is effectively regulated, the blood circulation is conditioned comprehensively, the SOD (Superoxide Dismutase) activity is increased, the invasion of free radicals is effectively blocked, maintaining and protecting effects are achieved, and the effect of delaying aging is achieved.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of regulating female incretion and preparation method thereof, belong to the field of Chinese medicines.
Background technology
Research is found, women's youthful vigor and appearance skin are directly related with kidney, ovarian function and estrogen and androgen balance etc., 30～40 years old women because bear children, the burdens such as family and work cause health " loss of transfiniting ", make the balance of kidney, ovarian function and estrogen and androgen that variation occur, so senile symptom appears in a lot of people.This is because these variations have caused the overtired of some organ cells of human body, but this real aging that is not organ, the aging phenomenon that shows is a kind of " false aging " in fact, this section is generally about 5 years period.Further research is found, the aging in women this period can reverse, improve kidney, ovarian function and regulate the material of estrogen and androgen balance if can replenish in right amount, organ cell tired in the body is rejuvenated, the youth that the woman also will become.
Summary of the invention
Problem to be solved by this invention provides a kind of good effect, Chinese medicine composition of the adjusting female incretion that toxic and side effects is low and preparation method thereof.
Technical scheme provided by the invention is: a kind of Chinese medicine composition of regulating female incretion, according to the mass fraction, be that raw material makes by 20～40 parts of Radixs Astragali, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Codonopsis, 10～20 parts of Rhizoma Chuanxiongs, 10～20 parts of Herba Epimedii, 10～20 parts of Herba Patriniae, 3～10 portions of Radix Glycyrrhizaes, 5～10 portions of Radix Curcumaes, 5～15 parts of Radix Polygalaes and 3～10 parts of Fructus Evodiaes.The present invention also provides the preparation method of above-mentioned Chinese medicine composition: the Chinese crude drug Radix Astragali, Radix Angelicae Sinensis, Radix Codonopsis, Rhizoma Chuanxiong, Herba Epimedii, Herba Patriniae, Radix Glycyrrhizae, Radix Curcumae, Radix Polygalae and Fructus Evodiae are dropped in the extraction element, use water extraction, after extracting solution is concentrated, concentrated, dry, pulverize to such an extent that regulate the Chinese medicine composition of female incretion.
HGH active factors and antioxidase that the present invention uses modern crafts to extract from the Chinese crude drugs such as the Radix Astragali, Radix Angelicae Sinensis, Radix Codonopsis, Rhizoma Chuanxiong, can strengthen the human body cell vigor, benefiting qi and nourishing blood, accelerate the drainage of internal metabolism refuse, blood circulation promoting and the hormonal secretion of women's ovary, replenish each seed amino acid, organized enzyme, mineral, the trace element of needed by human body, thereby reach effective endocrine regulation, the comprehensively regulating blood circulation, improve SOD active, the effectively invasion and attack of blocking-up free radical, the maintenance economic benefits and social benefits, thus reach the effect of slow down aging.
The specific embodiment
Embodiment 1:
A kind of Chinese medicine composition of regulating female incretion according to the mass fraction, is that raw material makes by 20 parts of Radixs Astragali, 10 parts of Radix Angelicae Sinensis, 10 parts of Radix Codonopsis, 10 parts of Rhizoma Chuanxiongs, 10 parts of Herba Epimedii, 10 parts of Herba Patriniae, 3 portions of Radix Glycyrrhizaes, 5 portions of Radix Curcumaes, 5 parts of Radix Polygalaes and 3 parts of Fructus Evodiaes.
Preparation method: by said ratio, all Chinese crude drugs are dropped in the extraction pot, the water that adds ten times of amounts extracts 3 times, after extracting solution is concentrated, to concentrate extracting solution with ethanol again and carry out precipitate with ethanol, remove unnecessary impurity, left standstill 36 hours, then extract the good supernatant of precipitate with ethanol, concentrated, then dry, pulverizing.
Embodiment 2:
A kind of Chinese medicine composition of regulating female incretion, according to the mass fraction, be that raw material makes by 30 parts of Radixs Astragali, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Codonopsis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Herba Epimedii, 15 parts of Herba Patriniae, 6 portions of Radix Glycyrrhizaes, 10 portions of Radix Curcumaes, 10 parts of Radix Polygalaes and 6 parts of Fructus Evodiaes.
Preparation method: by said ratio, all Chinese crude drugs are dropped in the extraction pot, the water that adds ten times of amounts extracts 3 times, after extracting solution is concentrated, to concentrate extracting solution with ethanol again and carry out precipitate with ethanol, remove unnecessary impurity, left standstill 36 hours, then extract the good supernatant of precipitate with ethanol, concentrated, then dry, pulverizing.
Embodiment 3:
A kind of Chinese medicine composition of regulating female incretion, according to the mass fraction, be that raw material makes by 40 parts of Radixs Astragali, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Codonopsis, 20 parts of Rhizoma Chuanxiongs, 20 parts of Herba Epimedii, 20 parts of Herba Patriniae, 10 portions of Radix Glycyrrhizaes, 10 portions of Radix Curcumaes, 15 parts of Radix Polygalaes and 10 parts of Fructus Evodiaes.
Preparation method: by said ratio, all Chinese crude drugs are dropped in the extraction pot, the water that adds ten times of amounts extracts 3 times, after extracting solution is concentrated, to concentrate extracting solution with ethanol again and carry out precipitate with ethanol, remove unnecessary impurity, left standstill 36 hours, then extract the good supernatant of precipitate with ethanol, concentrated, then dry, pulverizing.
Embodiment 4:
A kind of Chinese medicine composition of regulating female incretion, according to the mass fraction, be that raw material makes by 30 parts of Radixs Astragali, 10 parts of Radix Angelicae Sinensis, 15 parts of Radix Codonopsis, 10 parts of Rhizoma Chuanxiongs, 15 parts of Herba Epimedii, 20 parts of Herba Patriniae, 8 portions of Radix Glycyrrhizaes, 10 portions of Radix Curcumaes, 10 parts of Radix Polygalaes and 18 parts of Fructus Evodiaes.
By said ratio, preparation method: by said ratio, all Chinese crude drugs are dropped in the extraction pot, add the water of ten times of amounts, extract 3 times, after extracting solution is concentrated, will have concentrated extracting solution with ethanol again and carry out precipitate with ethanol, remove unnecessary impurity, left standstill 36 hours, then extract the good supernatant of precipitate with ethanol, concentrated, then dry, pulverizing.
Embodiment 5: regulate the Chinese medicine capsules of female incretion, adopt conventional capsule production technology to make the product of embodiment 1-4: mix → granulate → fill → polishing, screening → bubble-cap → inner packing → outer package → check → warehouse-in.
The clinical practice example:
The gorgeous sex of name: Chen Hong: woman's age: 32 is facial withered and yellow, and pachylosis, black eye are obvious, taking the Chinese medicine of prescription of the present invention (one) after the course for the treatment of, (each 2, take continuously 1 month Chinese medicine capsules, every day 2 times.) complexion become ruddy, skin smooth is flexible, black eye disappear, the complete obiteration of former symptom.The index that female incretion is six changes as follows:
Follotropin (FSH) (3.8) mIU/ml before by treatment, (normal value is 5～40 mIU/ml) changes (7.2) mIU/ml after the treatment into, and (normal value is 5～40mIU/ml).
Interstitialcellstimulating hormone (ICSH) (LH) (41) mIU/ml before by treatment, (normal value is 5～25mIU/ml), changes (25) mIU/ml after the treatment into, and (normal value is 5～40mIU/ml).
(normal value is 0.23～0.91nmol/L) to (0.14) nmol/L before by treatment of prolactin antagonist (PRL), and (normal value is 0.23～0.91nmol/L) to change (0.31) nmol/L after the treatment into.
Estradiol (E2) by treatment before (37) picomole/liter (normal value be 48～521 picomoles/liter) in ovulation later stage, change (215) picomole in ovulation later stage after the treatment/liter (normal value be 48～521 picomoles/liter) into.
(normal value is 7.6～97.6nmol/L) to progesterone (P), and (normal value is 7.6～97.6nmol/L) to change (39.2) nmol/L that treats the rear ovulation later stage into by treatment (8.2) nmol/L in front ovulation later stage.
(normal value is 0.7～3.1nmol/L) to (0.52) nmol/L before by treatment of testosterone (T), and (normal value is 0.7～3.1nmol/L) to change (1.1) nmol/L after the treatment into.
Name: Wang Li sex: woman's age: 41 yellowish complexion lips are light, have a dizzy spell, and trick is unable, the anemia constipation, also be accompanied by gynaecopathia, taking the Chinese medicine of prescription of the present invention (two) after the course for the treatment of, (Chinese medicine capsules, every day 2 times, each 2, took continuously 2 months).Have a dizzy spell, the unable symptom complete obiteration of trick, facial wrinkles is unfolded and is shoaled, and the constipation Anemia is significantly improved, and the gynaecopathia symptom has also obtained very large alleviation.The index that female incretion is six changes as follows:
Follotropin (FSH) (4.08) mIU/ml before by treatment, (normal value is 5～40 mIU/ml) changes (26.5) mIU/ml after the treatment into, and (normal value is 5～40mIU/ml).
Interstitialcellstimulating hormone (ICSH) (LH) (39) mIU/ml before by treatment, (normal value is 5～25mIU/ml), changes (21) mIU/ml after the treatment into, and (normal value is 5～40mIU/ml).
(normal value is 0.23～0.91nmol/L) to (0.13) nmol/L before by treatment of prolactin antagonist (PRL), and (normal value is 0.23～0.91nmol/L) to change (0.26) nmol/L after the treatment into.
Estradiol (E2) by treatment before (101) picomole/liter (normal value be 48～521 picomoles/liter) in ovulation later stage, change (327) picomole in ovulation later stage after the treatment/liter (normal value be 48～521 picomoles/liter) into.
(normal value is 7.6～97.6nmol/L) to progesterone (P), and (normal value is 7.6～97.6nmol/L) to change (52.8) nmol/L that treats the rear ovulation later stage into by treatment (7.4) nmol/L in front ovulation later stage.
(normal value is 0.7～3.1nmol/L) to (0.5) nmol/L before by treatment of testosterone (T), and (normal value is 0.7～3.1nmol/L) to change (1.2) nmol/L after the treatment into.
Name: Qin Lin jasmine sex: woman's age: 36 endocrine disturbance, ovary decline, chest distress and palpitation symptoms, the symptoms such as menoxenia.Taking the Chinese medicine of prescription of the present invention (three) after the course for the treatment of, (each 2, took continuously 3 months Chinese medicine capsules, every day 2 times.) endocrine recovered normally, the ovarian activity cell improves greatly, and the smooth and easy menstruation of gaseous pulse also becomes normally, and it is moist that whole skin also becomes, and the chest distress and palpitation symptoms symptom is also cured.The index that female incretion is six changes as follows:
Follotropin (FSH) (3.6) mIU/ml before by treatment, (normal value is 5～40 mIU/ml) changes (26) mIU/ml after the treatment into, and (normal value is 5～40mIU/ml).
Interstitialcellstimulating hormone (ICSH) (LH) (3.2) mIU/ml before by treatment, (normal value is 5～25mIU/ml), changes (35) mIU/ml after the treatment into, and (normal value is 5～40mIU/ml).
(normal value is 0.23～0.91nmol/L) to (0.16) nmol/L before by treatment of prolactin antagonist (PRL), and (normal value is 0.08～0.92nmol/L) to change (0.37) nmol/L after the treatment into.
Estradiol (E2) by treatment before (39) picomole/liter (normal value be 48～521 picomoles/liter) in ovulation later stage, change (198) picomole in ovulation later stage after the treatment/liter (normal value be 48～521 picomoles/liter) into.
(normal value is 7.6～97.6nmol/L) to progesterone (P), and (normal value is 7.6～97.6nmol/L) to change (66) nmol/L that treats the rear ovulation later stage into by treatment (7.2) nmol/L in front ovulation later stage.
(normal value is 0.7～3.1nmol/L) to (0.6) nmol/L before by treatment of testosterone (T), and (normal value is 0.7～3.1nmol/L) to change (1.1) nmol/L after the treatment into.
Claims (3)
1. Chinese medicine composition of regulating female incretion, it is characterized in that: according to the mass fraction, be that raw material makes by 20～40 parts of Radixs Astragali, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Codonopsis, 10～20 parts of Rhizoma Chuanxiongs, 10～20 parts of Herba Epimedii, 10～20 parts of Herba Patriniae, 3～10 portions of Radix Glycyrrhizaes, 5～10 portions of Radix Curcumaes, 5～15 parts of Radix Polygalaes and 3～10 parts of Fructus Evodiaes.
2. a kind of Chinese medicine composition of regulating female incretion according to claim 1, it is characterized in that: according to the mass fraction, be that raw material makes by 30 parts of Radixs Astragali, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Codonopsis, 15 parts of Rhizoma Chuanxiongs, 15 parts of Herba Epimedii, 15 parts of Herba Patriniae, 6 portions of Radix Glycyrrhizaes, 10 portions of Radix Curcumaes, 10 parts of Radix Polygalaes and 6 parts of Fructus Evodiaes.
3. the preparation method of claim 1 or 2 described Chinese medicine compositions, it is characterized in that: the Chinese crude drug Radix Astragali, Radix Angelicae Sinensis, Radix Codonopsis, Rhizoma Chuanxiong, Herba Epimedii, Herba Patriniae, Radix Glycyrrhizae, Radix Curcumae, Radix Polygalae and Fructus Evodiae are dropped in the extraction element, use water extraction, after extracting solution is concentrated, concentrated, dry, pulverize to get Chinese medicine composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110249809 CN102274468B (en) | 2011-08-29 | 2011-08-29 | Chinese medicinal composition for regulating female internal secretion and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110249809 CN102274468B (en) | 2011-08-29 | 2011-08-29 | Chinese medicinal composition for regulating female internal secretion and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102274468A CN102274468A (en) | 2011-12-14 |
| CN102274468B true CN102274468B (en) | 2013-04-03 |
Family
ID=45100410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110249809 Expired - Fee Related CN102274468B (en) | 2011-08-29 | 2011-08-29 | Chinese medicinal composition for regulating female internal secretion and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102274468B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103212037B (en) * | 2013-05-20 | 2014-06-18 | 晋茉莉 | Traditional Chinese medicine for treating female endocrine disorder and preparation method of traditional Chinese medicine |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008700A (en) * | 2010-12-14 | 2011-04-13 | 句容市边城卫生院 | Medicament for treating pelvic inflammation |
-
2011
- 2011-08-29 CN CN 201110249809 patent/CN102274468B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008700A (en) * | 2010-12-14 | 2011-04-13 | 句容市边城卫生院 | Medicament for treating pelvic inflammation |
Non-Patent Citations (2)
| Title |
|---|
| 傅灵梅 * |
| 等.尤昭玲教授论治多囊卵巢综合征经验述要.《中医药学刊》.2003,第21卷(第9期),1481,1528. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102274468A (en) | 2011-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101856430A (en) | Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof | |
| CN102283340A (en) | Nutrition enriched honey | |
| CN104706704B (en) | Maca composition, its compound preparation and its application | |
| CN102415459A (en) | Lily and orange peel tea | |
| CN105412353A (en) | Traditional Chinese medicine combination with functions of resisting senility, improving immunity, resisting fatigue and keeping healthy | |
| CN101292947A (en) | Skin care products with whitening function | |
| CN105055648A (en) | Anti-aging Chinese herbal medicinal health oral liquid containing shark cartilage powder and preparation method of oral liquid | |
| CN105412817A (en) | Rhodiola rosea compound oral liquid and preparation method thereof | |
| CN102846693B (en) | Composition used for relieving exercise-induced fatigue, and preparation method and application thereof | |
| CN105266149A (en) | Herba dendrodii officinalis compound health-care capsule and preparation method thereof | |
| CN102716401A (en) | Chinese herbal medicine composition for treating dermatosis | |
| CN102274468B (en) | Chinese medicinal composition for regulating female internal secretion and preparation method thereof | |
| CN106176550A (en) | Whitening Chinese medicament mask and preparation method thereof | |
| CN111388639B (en) | Phenylethanoid glycoside and isoflavone extract for relieving menopausal syndrome and application thereof | |
| CN103446384A (en) | Traditional Chinese medicine composition for decreasing blood sugar | |
| CN113826882A (en) | Dietary nutrition supplement for preventing and treating diabetes and preparation process thereof | |
| CN102114070A (en) | Compound traditional Chinese medicine for treating osteoporosis and preparation method thereof | |
| CN104606338A (en) | Electuary capable of quieting spirit and nourishing heart and preparation method thereof | |
| CN104524238A (en) | Preparation method of dendrobium officinale and pseudo-ginseng flower capsules | |
| CN105412854A (en) | Hair growth liquid and preparation method thereof | |
| CN105087299A (en) | Male silkworm moth wine and production method thereof | |
| CN104257733B (en) | A kind of Chinese medical extract of nti-freckle and preparation method thereof | |
| CN105998670A (en) | Aging delaying cherokee rose-hip oral liquid preparation method and oral liquid thereof | |
| CN105961677A (en) | Healthcare tea with effect of lubricating the intestines to relieve constipation and preparation method thereof | |
| CN105362668A (en) | Shenjing energy pills |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yuan Xuecai Inventor before: Li Hua Inventor before: Li Jincai |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170210 Address after: 233658 Anhui province city Guoyang County, Yi Hao town medicine Street No. 1 Patentee after: ANHUI YUANHETANG PHARMACEUTICAL Co.,Ltd. Address before: 437100 Xianning Hot Spring Development Zone Industrial Park, Hubei Patentee before: Hubei Kangjin Pharmaceutical Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210112 Address after: 236100 No.6, xiaozhouying natural village, zhouying administrative village, Yimen Town, Woyang County, Bozhou City, Anhui Province Patentee after: Anhui zhenhetang Pharmaceutical Co.,Ltd. Address before: 233658 No.1, yaocai street, Yimen Town, Woyang County, Haozhou City, Anhui Province Patentee before: ANHUI YUANHETANG PHARMACEUTICAL Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |